Richard /ca/ Murray
Sr. VP & CSO, PDL BIOPHARMA, INC.
Companies
- Jounce TherapeuticsBoard member Jan 26, 2017 to May 4, 20231
- Jounce TherapeuticsChief executive officer Jan 26, 2017 to Jan 11, 20231
- Jounce TherapeuticsPresident Jan 26, 2017 to Jan 11, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Jounce Therapeutics JNCE1 shares2May 3, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- May 3, 2023U 188,778 shares of Jounce Therapeutics2
- Apr 4, 2023Sold 39,228 shares at $1.85 of Jounce Therapeutics3
- Jan 10, 2023Sold 24,879 shares at $1.12 of Jounce Therapeutics4
- Jan 9, 2023Sold 20,191 shares at $1.10 of Jounce Therapeutics4
- Feb 1, 2022Granted 87,500 shares of Jounce Therapeutics5
- Jan 10, 2022Sold 23,924 shares at $6.65 of Jounce Therapeutics6
- Jan 7, 2022Sold 13,370 shares at $7.30 of Jounce Therapeutics6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARJounce Therapeutics, Board member
- 2
- 3SEC EDGARForm 4 filed Apr 6, 2023
- 4SEC EDGARForm 4 filed Jan 11, 2023
- 5SEC EDGARForm 4 filed Feb 3, 2022
- 6SEC EDGARForm 4 filed Jan 11, 2022